[Therapeutic strategies in menstrual migraine].
D001921:Brain / Q000503:physiopathology*; D004878:Ergotamine / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008593:Menopause; D008597:Menstrual Cycle / Q000502:physiology; D008598:Menstruation; D008881:Migraine Disorders / Q000188:drug therapy / Q000503:physiopathology*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D006728:Hormones; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D004958:Estradiol; D018170:Sumatriptan; D004878:Ergotamine
Estrategias terapéuticas en la migraña menstrual.